Liver spontaneous hypoattenuation on CT is an imaging biomarker of the severity of acute pancreatitis

Diagnostic and interventional imaging - Tập 103 - Trang 401-407 - 2022
Benjamin Roussey1, Paul Calame1,2, Lucie Revel1, Thibaut Zver1, Anhum Konan1, Gael Piton3, Stephane Koch4, Lucine Vuitton4, Eric Delabrousse1,2
1Department of Radiology, University of Bourgogne Franche-Comté, CHRU Besançon, 25030, Besançon, France
2EA 4662 Nanomedicine Lab, Imagery and Therapeutics, University of Franche-Comté, 25030, Besançon, France
3Medical Intensive Care Unit, University of Bourgogne Franche-Comté, CHRU Besançon, 25030, Besançon, France
4Department of Gastroenterology, University of Bourgogne Franche-Comté, CHRU Besançon, 25030 Besançon, France

Tài liệu tham khảo

Vege, 2018, Initial medical treatment of acute pancreatitis: American Gastroenterological Association Institute technical review, Gastroenterology, 154, 1103, 10.1053/j.gastro.2018.01.031 Beyer, 2020, Chronic pancreatitis, Lancet, 396, 499, 10.1016/S0140-6736(20)31318-0 Lankisch, 2015, Acute pancreatitis, Lancet, 386, 85, 10.1016/S0140-6736(14)60649-8 Türkvatan, 2015, Imaging of acute pancreatitis and its complications. Part 2: complications of acute pancreatitis, Diagn Interv Imaging, 96, 161, 10.1016/j.diii.2013.12.018 Park, 2020, Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features, Diagn Interv Imaging, 101, 555, 10.1016/j.diii.2020.03.002 Zver, 2022, Early prediction of acute biliary pancreatitis using clinical and abdominal CT features, Radiology, 302, 118, 10.1148/radiol.2021210607 Meyrignac, 2015, Acute pancreatitis: extrapancreatic necrosis volume as early predictor of severity, Radiology, 276, 119, 10.1148/radiol.15141494 Pamies-Guilabert, 2020, Pancreatic necrosis volume: a new imaging biomarker of acute pancreatitis severity, Eur J Radiol, 130, 10.1016/j.ejrad.2020.109193 Hou, 2019, Fatty liver disease is associated with the severity of acute pancreatitis: a systematic review and meta-analysis, Int J Surg, 65, 147, 10.1016/j.ijsu.2019.04.003 Váncsa, 2020, Fatty liver disease and non-alcoholic fatty liver disease worsen the outcome in acute pancreatitis: a systematic review and meta-analysis, J Clin Med, 9, E2698, 10.3390/jcm9092698 Gao, 2016, Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe?, Gastroenterology, 150, 1704, 10.1053/j.gastro.2016.01.025 Grillet, 2021, Non-invasive diagnosis of severe alcoholic hepatitis: usefulness of cross-sectional imaging, Diagn Interv Imaging, 102, 247, 10.1016/j.diii.2020.09.009 Graffy, 2019, Automated liver fat quantification at nonenhanced abdominal CT for population-based steatosis assessment, Radiology, 293, 334, 10.1148/radiol.2019190512 Ma, 2009, Imaging-based Quantification of hepatic fat: methods and clinical applications, Radiographics, 29, 1253, 10.1148/rg.295085186 Kodama, 2007, Comparison of CT methods for determining the fat content of the liver, Am J Roentgenol, 188, 1307, 10.2214/AJR.06.0992 Cerit, 2020, Quantification of liver fat content with ultrasonographic attenuation measurement function: correlation with unenhanced multidimensional computerized tomography, Clin Imaging, 65, 85, 10.1016/j.clinimag.2020.04.028 Jirapatnakul, 2020, Automated measurement of liver attenuation to identify moderate-to-severe hepatic steatosis from chest CT scans, Eur J Radiol, 122, 10.1016/j.ejrad.2019.108723 Banks, 2013, Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus, Gut, 62, 102, 10.1136/gutjnl-2012-302779 Marshall, 1995, Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome, Crit Care Med, 23, 1638, 10.1097/00003246-199510000-00007 Balthazar, 2002, Acute pancreatitis: assessment of severity with clinical and CT evaluation, Radiology, 223, 603, 10.1148/radiol.2233010680 Benchoufi, 2020, Interobserver agreement issues in radiology, Diagn Interv Imaging, 101, 639, 10.1016/j.diii.2020.09.001 van den Berg, 2020, Early laboratory biomarkers for severity in acute pancreatitis: a systematic review and meta-analysis, Pancreatology, 20, 1302, 10.1016/j.pan.2020.09.007 Papachristou, 2010, Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis, Am J Gastroenterol, 105, 435, 10.1038/ajg.2009.622 Xu, 2015, Influence of fatty liver on the severity and clinical outcome in acute pancreatitis, PLoS ONE, 10 Yoon, 2017, Impact of fatty liver on acute pancreatitis severity, Gastroenterol Res Pract, 2017, 10.1155/2017/4532320 Mikolasevic, 2017, Nonalcoholic fatty liver and the severity of acute pancreatitis, Eur J Intern Med, 38, 73, 10.1016/j.ejim.2016.10.019 Gupta, 2021, Development and validation of a computed tomography index for assessing outcomes in patients with acute pancreatitis: “SMART-CT” index, Abdom Radiol, 46, 1618, 10.1007/s00261-020-02740-y Wang, 2015, Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis, Sci Rep, 5, 17833, 10.1038/srep17833 Seitz, 2018, Alcoholic liver disease, Nat Rev Dis Primers, 16, 16, 10.1038/s41572-018-0014-7 Madico, 2019, Intra peritoneal abdominal fat area measured from computed tomography is an independent factor of severe acute pancreatitis, Diagn Interv Imaging, 100, 421, 10.1016/j.diii.2019.03.008 Pickhardt, 2021, Liver steatosis categorization on contrast-Enhanced CT using a fully automated deep learning volumetric segmentation tool: evaluation in 1204 healthy adults using unenhanced CT as a reference standard, AJR Am J Roentgenol, 217, 359, 10.2214/AJR.20.24415 Hahn, 2015, Longitudinal changes in liver fat content in asymptomatic adults: hepatic attenuation on unenhanced CT as an imaging biomarker for steatosis, AJR Am J Roentgenol, 205, 1167, 10.2214/AJR.15.14724 Lawrence, 2018, Opportunistic screening for hereditary hemochromatosis with unenhanced CT: determination of an optimal liver attenuation threshold, AJR Am J Roentgenol, 211, 1206, 10.2214/AJR.18.19690 Esser, 2014, Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes, Diabetes Res Clin Pract, 105, 141, 10.1016/j.diabres.2014.04.006 Elks, 2010, Central adiposity, systemic inflammation, and the metabolic syndrome, Curr Hypertens Rep, 12, 99, 10.1007/s11906-010-0096-4 de Laforcade, 2021, Kidney and contrast media: Common viewpoint of the French Nephrology societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelines, Diagn Interv Imaging, 102, 131, 10.1016/j.diii.2021.01.007